Q3 2022 BioNTech SE Earnings Call Transcript
Welcome to the BioNTech Third Quarter 2022 Update Call. I would like to hand the call over to the Vice President of Investor Relations and Strategy, Sylke Maas. Please go ahead, Sylke.
Thank you all for joining us today as we review our third quarter operational highlights and provide you with some financial update. BioNTech is in exciting phase of its corporate development, and we are delighted to share our progress with you. A few housekeeping items before we start. I invite you to view the slides that accompany the webcast and the third quarter 2022 press release, both of which were issued this morning and can be found in the Investors section of our website.
Taking the first look at Slide 2, I would like to remind you that during today's presentation, we will make several forward-looking statements. These forward-looking statements include, but are not limited to our COVID-19 vaccine revenues as we include figures that are derived from preliminary estimates provided by our partners, our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |